The latest round of layoffs will see Sage reduce 33% of its total workforce. Credits: Wirestock Creators/Shutterstock.com ...

Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety between teenagers and adults in an NIH study.

The company’s keratoconus medication, Epioxa, was effective in a Phase III trial, with plans to file for submission with the ...

Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating ...

Acadia Pharmaceuticals has received marketing authorisation from Health Canada for DAYBUE (trofinetide) to treat Rett ...

Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commercialise sotagliflozin outside the US and ...

After a hearing held on 25 September 2024, the European Patent Office (EPO) affirmed bit.bio’s claim against an anonymous ...

Seltorexant is one of J&J’s most promising neuroscience candidates. The human orexin-2 receptor selective agonist produced ...

Synedgen has announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to develop ...

A new generation of remote monitoring devices in Scotland is helping to reduce the burden on healthcare systems and improve ...

UroGen Pharma has received the NDA acceptance from the US FDA for UGN-102 (mitomycin) to treat bladder cancer.

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...